Site updated at Wednesday, 22 June 2016

Living with Dementia


Georgetown physician leads national resveratrol study for Alzheimer’s disease

A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer’s disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center’s Memory Disorders Program, is the lead… Georgetown physician leads national resveratrol study for Alzheimer’s disease   


early-stage parkinsons1 - alzheimer's32 - abnormal blood clotting1 - semantic dementia1 - alzheimer's causes1 - poor judgment2 - cholinesterase inhibitors1 - vitamin b-11 - mediterranean1 - alzheimer's disease biomarkers1 - loss of balance1 - alzheimer's disease195 - muscle co-ordination1 - memory loss20 - difficulties with speech1 - memory restoration1 - parkinson's drug2 - early-onset alzheimer's disease1 - psychiatric status rating scales1 - cognitive decline19 - mild alzheimer's stage1 - cardiac arrest1 - drug addiction1 - high blood pressure7 - stage dementia1 - alzheimer's warning signs1 - amyloid beta precursor protein1 - deficiency of thiamine1 - dementia135 - ssri2 -